Clinical Trials Browser

Phase NA × Specimen Handling × Gynecologic × Clear all

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT06498661 2026-04-01

SHIP-A-S01

Phase NA Recruiting

750 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04251052 2026-03-27

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Phase NA Recruiting

1,956 enrolled

Gynecologic

Ovarian Neoplasms

NCT07281430 2026-02-17

LMI-001-A-S04

Phase NA Recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06855706 2026-01-06

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Phase NA Recruiting

120 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06611540 2025-12-30

LMI-001-A-S03

Phase NA Active not recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2025-12-15

LMI-001-A-S02

Phase NA Active not recruiting

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT05047926 2025-08-08

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Phase NA Completed

90 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Phase NA Completed

152 enrolled

BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Clinical Trials

The Vanguard Study: Testing a New Way to Screen for Cancer

SHIP-A-S01

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

LMI-001-A-S04

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

LMI-001-A-S03

LMI-001-A-S02

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study